Editorial · 31 Dec 2025
Review articlePublished 11 Aug 2021
Diagnostic and Prognostic Biomarkers of Heart Failure: The Impacts, Implementation and Future Outcomes
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Heart failure (HF) is a major leading cause of mortality and morbidity worldwide. The primary and secondary preventions of chronic heart failure are a priority for the health system and require multiple approaches to increase their effectiveness. Serum Cardiac Biomarkers are tools used to more accurately identify high-risk individuals of chronic Heart Failure, to speed the diagnosis, and to aid in treatment and prognosis determination. This review aims to highlight the importance of utilization of a variety of these cardiac biomarkers in assessment of asymptomatic HF patients, and decompensated symptomatic cases of chronic heart failure and to raise relevant points of their clinical use and the promises for the coming years for better management under different types of pharmacotherapeutic lines for treatment of chronic heart failure.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Research & Reviews: Journal of Hospital and Clinical Pharmacy.
Editorial · 31 Dec 2025
Clinical Guidelines: Standardizing Care for Improved Patient Outcomes
Editorial · 31 Dec 2025
Quality Improvement and Evidence-Based Practice: Enhancing Healthcare Outcomes
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalResearch & Reviews: Journal of Hospital and Clinical Pharmacy
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Ahmed Bader”